Managing Resistance to Anti-HIV Drugs
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 57 (3), 337-361
- https://doi.org/10.2165/00003495-199957030-00006
Abstract
Current recommendations for the treatment of HIV-infected patients advise highly active antiretroviral therapy (HAART) consisting of combinations of 3 or more drugs to provide long-term clinical benefit. This is because only a complete suppression of virus replication will be able to prevent virus drug resistance, the main cause of drug failure. Virus drug resistance may remain a cause of concern in patients who have already received suboptimal mono- or bitherapy, or for patients who do not experience complete shut-down of virus replication under HAART For these patients, replacement of one combination therapy regimen by another at drug failure, taking into account the existing resistance profile, will be needed. The development of new drugs will remain necessary for those patients who have failed to respond to all currently available drugs, as will be the institution of more effective and less toxic HAART regimens.Keywords
This publication has 82 references indexed in Scilit:
- Human Immunodeficiency Virus Type-1 Reverse TranscriptaseJournal of Biological Chemistry, 1996
- Enzymatic Characterization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Resistant to Multiple 2′,3′-Dideoxynucleoside 5′-TriphosphatesJournal of Biological Chemistry, 1995
- The Appearance of Drug Resistance-Associated Point Mutations in HIV Type 1 Plasma RNA Precedes Their Appearance in Proviral DNAAIDS Research and Human Retroviruses, 1995
- 2′,3′-Dideoxycytidine induced drug resistance in human cellsLife Sciences, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- Comparison of the Sensitivities of Primary Isolates of HIV Type 2 and HIV Type 1 to Antiviral Drugs and Drug CombinationsAIDS Research and Human Retroviruses, 1994
- Genotypic And Phenotypic Analysis Of Human Immunodeficiency Virus Type 1 Isolates From Patients On Prolonged Stavudine TherapyThe Journal of Infectious Diseases, 1994
- Locations of Anti-AIDS Drug Binding Sites and Resistance Mutations in the Three-dimensional Structure of HIV-1 Reverse TranscriptaseJournal of Molecular Biology, 1994